Search results
Huawei’s latest smartphone contains more China-made components than Mate 60
South China Morning Post· 6 days ago“We don’t think revoking the chipset export licence will significantly impact Huawei’s smartphone...
Earnings call: Baidu's Q1 2024 earnings show steady growth in AI and cloud By Investing.com
Investing.com· 7 days agoBaidu, Inc. (NASDAQ: BIDU), a leading Chinese technology firm specializing in Internet-related...
‘Inhumane’: Utah mom slaps drug company with lawsuit after suffering COVID vaccine trial injuries
Fox News· 6 days agoEXCLUSIVE: A Utah mother says she was left with "no choice" but to sue a pharmaceutical company on...
Silver economy reshaping biz strategies
China Daily· 13 hours agoHao Yuling, a 64-year-old retiree in Beijing, had an unforgettable 10-day group trip in September 2003 to five European countries. Then from Germany, she arrived in Paris, visiting the Eiffel ...
Opinion | Western concerns about Chinese oversupplies are woefully misplaced
South China Morning Post· 4 days agoChina’s ambitions to recover its “proper” place in the world were always going to be problematic for...
‘Inhumane’: Utah mom slaps drug company with lawsuit after suffering COVID vaccine trial injuries
AOL· 6 days agoEXCLUSIVE: A Utah mother says she was left with "no choice" but to sue a pharmaceutical company on the basis of a breached contract that promised to provide compensation for injuries caused ...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 7 days agoHONG KONG, SHANGHAI and FLORHAM PARK, N.J., May 17, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that topline and subgroup results from the ESLIM-01 Phase III study of sovleplenib,
